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Background and Aim. We evaluated the usefulness of background coloration (BC), a color change in the area between intrapapillary
capillary loops (IPCLs) in the early esophago-pharyngeal lesions using NBI with magnificaiton. Methods. Between April 2004 and
March 2010, a total of 294 esophago-pharyngeal lesions were examined using NBI with magnification, and the presence of BC
and IPCL patterns were assessed. Using BC, discrimination of squamous cell carcinoma (SCC) or high-grade neoplasia (HGN)
from low-grade neoplasia (LGN) or nonatypia was conducted. Results. Among 294 lesions, 209 lesions (71.1%) were positive
for BC, while 85 (28.9%) were negative. In the BC-positive group, 187 lesions (89.5%) were diagnosed as SCC/HGN. And 68
lesions (80.0%) in the BC-negative group were diagnosed as LGN/nonatypia. Overall accuracy of BC to discriminate SCC/HGN
from LGN/nonatypia was 87.3%. The sensitivity and specificity were 91.9%, 76.7%. BC could discriminate SCC/HGN from LGN/
nonatypia accurately (P < 0.0001). Among 68 lesions classified into the IPCL type IV, the BC-positive group (n = 26) included 21
SCC/HGN lesions, while there were 36 LGN/nonatypia lesions in the 42 BC-negative lesions. Conclusions. BC is a useful finding
in differentiating SCC/HGN from LGN/nonatypia lesions in the esophagus especially when it is combined with IPCL pattern
classification.
1. Introduction
The usefulness of narrowband imaging (NBI) magnification
in detecting early esophago-pharyngeal lesions including
noninvasive high grade neoplasia and invasive squamous cell
carcinoma (SCC) has already been reported [1, 2]. Using
NBI, such esophago-pharyngeal lesions are recognized as
brown-colored area. Magnified endoscopic observation with
NBI has been performed to visualize intrapapillary capillary
loops (IPCLs) [3–5], the superficial microvascular architec-
ture in the mucosa covered with squamous epithelia. Figure 1
shows IPCL pattern classification, which was introduced by
Inoue in 2001. The IPCL pattern is useful in the diagnosis of
the depth of tumor invasion for esophago-pharyngeal squa-
mous cell neoplasms. Nevertheless, distinguishing malignant
from noncancerous lesions is sometimes difficult even for
experienced endoscopists.
We have found that background coloration (BC), a color
change in the area between IPCL, is seen in the esophago-
pharyngeal neoplastic lesions but not in the benign lesions
using NBI with magnifying endoscopy. Therefore, we sought
to determine whether BC could discriminate SCC or high-
grade neoplasia (HGN) from low-grade neoplasia (LGN) or
nonatypia.
2. Methods
2.1. Patients. Three hundred and seventy lesions, which were
found between April 2004 and March 2010 in our institution,
were enrolled in this study. One lesion without pathology and
53 lesions without detailed magnifying observation of IPCL
pattern were excluded. And 7 cases were excluded because
the margin of the brownish area was difficult to be identified
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Figure 1: IPCL pattern classification, which was introduced by Inoue et al. in 2001. Most of IPCL type I to III is corresponding to benign
pathology including inflammation and low grade neoplasia (LGN). Approximately 50% of IPCL type IV is corresponding to LGN, and the
rest is corresponding to malignant pathology including high grade neoplasia (HGN). IPCL type V is a malignant pattern and subclassified
into 4 categories. V1 and V2 could be removed by endoscopic resection (ER) such as EMR and ESD. IPCL type V3 includes m3 and sm1
cancers. IPCL type Vn is a pattern for massively submucosally invasive cancers. ∗CRT: chemoradiotherapy.
(IPCL type II). In total, two hundred and twenty-two
patients (male : female = 169 : 53) aged 67.0±16.0 y.o. (range
45–92 y.o., median 68.5 y.o.) with 294 lesions were enrolled
in this study. Two hundred and thirty lesions were treated by
endoscopic mucosal resection/endoscopic submucosal dis-
section (EMR/ESD), and 64 lesions were pathologically con-
firmed by biopsy. The mean diameter of the lesions was
15.3 mm (range 1–95 mm, median 10 mm).
All samples were obtained with the written informed
consent of the patients prior to their inclusion, in accordance
with the Helsinki Declaration and under approval by the
Showa University Ethics Committee.
2.2. Endoscopic Examination. We used GIF-H260Z (Olym-
pus medical systems Co., Tokyo, Japan) comprising a high-
resolution white-light video endoscope equipped with NBI
system. An NBI system has a high-resolution mode in which
the white light image (WLI) is composed of sequential
images taken through red, green, and blue (RGB) bandpass
filters. In NBI mode, the central wavelengths of the RGB
filters (445 nm (blue), 540 nm (green), and 620 nm (red)) are
narrowed to 415 nm (blue) and 540 nm (green). Using the
wavelength dependence of the light penetration depth into
the mucosa and the hemoglobin absorption characteristics
in the surface layer, NBI technology allows the mucosal
surface layer to be displayed in high contrast and enhances
hemoglobin-rich areas such as blood vessels.
Patients underwent upper endoscopy under conscious
sedation with intravenous pethidine hydrochloride (35–
70 mg, Mitsubishi Tanabe Pharmaceutical Co., Osaka, Japan)
supplemented with Diazepam (5–10 mg, Takeda Pharmaceu-
tical Co., Osaka, Japan). In order to suppress esophageal peri-
stalsis, either scopolamine butylbromide (20 mg, Boehringer
Ingelheim GmbH, Ingelheim, Germany) or glucagon (1-
2 mg, Novo Nordisk, Bagsværd, Denmark) was also admin-
istered intravenously. All procedures were carried out by two
experienced endoscopists (M.H. and H.I.).
After a brownish area was found with NBI, the lesion
was observed with NBI magnification to be classified into
IPCL pattern classification that has been introduced by Inoue
et al. IPCL pattern classification has been reported to be
a useful tool to discriminate cancer and dysplasia from
benign lesions. Inoue classified esophageal lesions into five
categories depending on the irregularity of the IPCL. IPCL
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Figure 2: (a) Positive for background coloration (left panel). Color of the space between each dilated IPCL is brownish compared to normal
IPCL area, as pointed out in schema (right image). (b) Endoscopic resection was carried out. Pathological result was T1a-LPM squamous cell
carcinoma (squamous cell carcinoma, moderately differentiated type, pT1a-LPM, INFb, ly0, v0, pHM0, pVM0).
pattern classification has five categories, and each of them is
corresponding to the pathology from benign to squamous
cell carcinoma.
Then, the lesion was observed with NBI magnification,
and BC was evaluated. If there is a color change in the area
between IPCLs, the lesion was regarded as being positive for
BC (Figures 2(a) and 2(b)). If there is no color change in
the area, the lesion was regarded as being negative for BC
(Figures 3(a) and 3(b)). For larger lesions with heteroge-
neous BC findings, we categorized the lesion into BC positive
group if BC-positivity was clearly observed at least in one
part of the lesion.
2.3. Histological Evaluation. Each specimen resected by
EMR/ESD was fixed in 10% formalin and embedded in
paraffin wax. The tissue specimens were cut at a thickness of
2 mm, and all sections were routinely evaluated for patho-
logical diagnosis. Biopsy specimens collected by endoscopists
on suspicion of or to rule out SCC were also used to
examine diagnostic histological findings. All specimens were
evaluated by experienced gastrointestinal pathologists. His-
tology was assessed according to the following four categories
of Vienna classification: invasive SCC, HGN, low-grade
neoplasia (LGN), and negative or indefinite for neoplasia
(nonatypia).
2.4. Statistical Analysis. Sensitivity, specificity, positive pre-
dictive value, negative predictive value, and overall accuracy
of identifying HGN or SCC were estimated for BC and IPCL
pattern classification, using histological findings as the gold
standard. P values <0.05 were considered to be statistically
significant. Data were analyzed using Statview Version 5.0
(SAS Institute Co., Cary, NC).
3. Results
Among 294 lesions, 209 lesions (71.1%) were positive for
BC and 85 lesions (28.9%) were negative. As shown in
Table 1, most invasive SCC (99.1%) and the majority of HGN
(82.2%) showed BC positivity. Thus, 91.6% of HGN/invasive
Table 1: Histological diagnosis for 294 esophago-pharyngeal
lesions. More than 90% of BC positive lesions were histologically
confirmed as HGIN or SCC. On the other hand, 80.0% of BC nega-


























Table 2: Significant correlation was seen between tumor depth and









22 74 70 43
(24.4%) (82.2%) (98.6%) (100%)
BC (−) 68 16 1 0
(75.6%) (17.8%) (1.4%) (0%)
Total 90 90 71 43
SCC was diagnosed positive for BC. On the other hand, 68
lesions (80.2%) in the BC-negative group were nonatypia
(mostly inflammatory change) or LGN. Overall accuracy
of BC for discrimination of HGN and invasive SCC was
87.3%. Sensitivity, specificity, positive predictive value, and
negative predictive value were 91.9%, 76.7%, 90.1%, and
80.2%, respectively.
Table 2 shows correlation between tumor invasion depth
and BC positivity. There was significant increase in positive
rates of BC in proportion to the tumor invasion depth. On
the contrary, BC negative rates were decreased in association
with the tumor infiltration depth.
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Figure 3: (a) Negative for background coloration (left panel). The color of the area between dilated IPCL is same to surrounding normal
IPCL area as pointed out in schema (right image). (b) The lesion was pathologically confirmed as inflamed mucosa by biopsy.
It has been reported that IPCL type III is a typical pat-
tern for benign lesions including nonatypia and LGN, while
the type V is highly suggestive of SCC in Japanese literature.
In line with this, we confirmed that the type III and V
could clearly discriminate invasive SCC/HGN from LGN/
nonatypia. In contrast, type IV was inconclusive, as lesions
classified into this IPCL pattern included substantial num-
bers of HGN/SCC and LGN/nonatypia. Lesions with IPCL
type III, which usually represent inflammation or LGN, can
be carefully observed. IPCL type V which is corresponding to
malignancy obviously requires some treatment including
EMR/ESD. However, IPCL type IV is still inconclusive
because more than half of them are nonmalignant. We pro-
pose that IPCL type IV lesions should be considered for
pathological confirmation. How to make more reliable endo-
scopic diagnosis or whether to remove or not has been a
problem of great interest.
Focusing on IPCL pattern IV, 41 of 68 lesions showed
BC negativity, and 36 (85.7%) of them were pathologically
confirmed as nonatypia or LGN. On the other hand, 22
(81.5%) of 27 lesions, which were diagnosed as BC positive,
were pathologically HGN or SCC (Table 3). In this study,
overall accuracy of BC in lesions showing IPCL type IV was
no less than 85.3%. Similarly to the IPCL type V group, sta-
tistically significant interrelation between BC and pathology
was seen (P < 0.0001). The accuracy of IPCL pattern IV
was significantly improved when it was combined with BC
(Table 4). Therefore, BC added significant improvement in
diagnostic ability of IPCL classification.
In order to evaluate the cause of BC, we compared two
parts of the same lesion, which was positive for BC and neg-
ative for it (Figure 4). Histopathologically some differences
were seen in number of cells, N/C ratio, thickness of stratum
corneum layer, and level of inflammatory cells infiltration.
4. Discussion
Iodine staining has been utilized to detect esophageal squa-
mous cell carcinoma as the most reliable diagnostic tool [6,
7]. Previously reported data shows that the diagnostic accu-
racy of differentiating SCC from all the Lugol voiding lesions
Table 3: Relation between IPCL pattern classification and pathol-
ogy, P < 0.0001.
Nonatypia/LGIN HGIN/invasive SCC
IPCL type III 39 (95.1%) 2 (4.9%)
IPCL type IV 41 (60.3%) 27 (39.7%)
IPCL type V 10 (5.4%) 175 (94.6%)
Table 4: BC pairing with IPCL type IV significantly improved the
diagnostic accuracy in detecting squamous cell carcinoma including
HGN.





BC (−) 41 LGIN 36
HGIN/SCC 5
was 13.0 to 33% [8, 9]. Ohmori et al. reported that pinkish
color change few minutes after spraying iodine is useful to
differentiate SCC from benign changes [10, 11]. However,
iodine staining has certain unfavorable aspects such as pro-
longation of the procedure time, iodine allergy in some
patients, and uncomfortable side effects including chest dis-
comfort and cough. It is therefore difficult to apply iodine
staining to all patients other than high-risk populations
such as patients with a history of head and neck cancer,
heavy smokers, and alcohol abusers. Especially in the oro-
pharyngeal region, chromoendoscopy with iodine staining
cannot be easily applied because of these uncomfortable
effects.
On the other hand, NBI system is easily applied by
pushing a button on the endoscope without efforts of spray-
ing iodine or waiting for the color change. Takenaka and
Kuraoka et al. compared NBI with chromoendoscopy with
iodine staining in detection for esophageal SCC or HGN [12,
13]. They reported that NBI was significantly superior to the
chromoendoscopy in the overall accuracy of detection. Also
Muto et al. reported that NBI combined with magnifying
endoscopy significantly improved the detection rates for
SCC with quite high sensitivity [14]. However, specificity







Figure 4: To evaluate the pathological difference between background mucosa (BC negative) and cancerous area (BC positive), we compared
two lesions that were positive for BC and negative for it. See the differences in number of cells, N/C ratio, state of keratosis, level of
inflammatory cells infiltration.
for esophageal region was 42.1% that still is not sufficient.
Kuraoka assessed the reason of this relatively low specificity
as hypervascularity due to inflammation and improper kera-
tinization [12].
Inoue et al. already reported IPCL pattern classification
as an effective diagnostic tool in detecting squamous cell
carcinoma [3–5]. Overall accuracy, sensitivity, specificity,
positive predictive value, and negative predictive value have
been reported to be 82.9%, 97.3%, 66.2%, 77.0%, and 95.4%.
IPCL type I, II, and III are corresponding to benign pathol-
ogy including LGN. On the other hand, IPCL type IV and V
are expected to represent malignancy including HGN. They
have reported that diagnostic accuracy of IPCL type III and
type V is 94.8% and 89.4%, which is sufficient, respectively.
However, more than 50% of the lesions that were diagnosed
as IPCL type IV were pathologically proved to be benign.
This means that there are some risks of overdiagnossis, pos-
sibly leading to overtreatment.
In contrast, assessment using BC resulted in high sensi-
tivity and specificity for distinguishing between HGN/SCC
and LGN/nonatypia. Moreover, focusing on IPCL type IV,
BC added significant improvement in diagnostic ability of
IPCL classification.
It is beyond the scope of this study to explore what BC
represents. There were some histopathological differences in
number of cells, N/C ratio, thickness of stratum corneum
layer, and level of inflammatory cells infiltration between the
BC-positive and the surrounding BC-negative one as shown
in Figure 3. Fujii et al. evaluated the correlation between
density of microvessels and pathology [15]. They reported
that microvascular density increases step by step from basal
cell hyperplasia through dysplasia to carcinoma. These find-
ings may explain in part the BC significance. Also NBI
image mechanically reflects the wavelength that is specific
to hemoglobin. This means that the cause of BC potentially
carries another possibility such as existence of red blood cells
in intra- or extraepithelium. The cause of this phenomenon
is still quite uncertain, and there are many possibilities. And
clearly, further studies are needed to illuminate this issue.
This is a single center prospective study. There should also be
needed further prospective study to elucidate the limitations
such as intra- and interobserver variations.
In conclusion, BC positivity seems to be a useful and reli-
able finding for suggestive malignant lesions in the esopahgo-
pharyngeal area. This finding has to be solidified by measur-
ing intra- and interobserver variation. In combination with
IPCL pattern classification, BC can provide additional infor-
mation on accurate discrimination of SCC/HGN from LGN/
nonatypia.
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